|
E.A. Kovalenko, A.N. Bogolepova
POST-STROKE COGNITIVE IMPAIRMENT: NEW PERSPECTIVES FOR NEUROPROTECTION
|
№9 / 2016
|
|
E.I. Astashkin, M.G. Glezer
DISCIRCULATORY ENCEPHALOPATHY: CLINICAL FEATURES, DIAGNOSIS AND TREATMENT OPTIONS
|
№9 / 2015
|
|
V.V. Zakharov
DRUG THERAPY IN REHABILITATION PERIOD AFTER STROKE
|
№9 / 2015
|
|
T.V. Potupchik (1), O.F. Veselova (1), L.S. Evert (2)
PHARMACODYNAMIC ASPECTS OF USE OF SOME NOOTROPICS IN COGNITIVE DISORDERS
|
№13 / 2014
|
|
E.A. Ushkalova (1), A.V. Ushkalova (2)
APPLICATION OF CHOLINE ALFOSCERATE AND ITS COMBINATION WITH ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE IN THE THERAPY OF SOMATIC PATIENTS WITH COGNITIVE DISORDERS
|
№20 / 2013
|
|
E.A.Katunina
VASCULAR COGNITIVE IMPAIRMENTS AND POTENTIALS FOR THEIR CORRECTION
|
№7 / 2013
|
|
V.K. Bochkarev, A.Z. Phaizulloev
Electroencephalographic Correlates Of Asthenic Disorders And Cognitive Impairment During Therapy With Neuroprotective Drugs: Results Of Coherent Analysis
|
№20 / 2011
|
|
Ye.A. Drozdova
Application Of Actovegin And Ceraxon For Correction Of Cognitive Disorders In Mild Traumatic Brain Injury
|
№14 / 2011
|
|
L.S. Kanaeva
Potential For Pantogam Use In Medical Practice
|
№6 / 2009
|
Русский
